Literature DB >> 12654790

Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth.

S Worku1, D F Hoft.   

Abstract

We investigated the effects of peripheral blood mononuclear cells expanded with irrelevant control and mycobacterial antigens on the intracellular growth of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in human macrophages. More than 90% of the cells present after 1 week of in vitro expansion were CD3(+). T cells were expanded from purified protein derivative-negative controls, persons with latent tuberculosis, and BCG-vaccinated individuals. T cells expanded with nonmycobacterial antigens enhanced the intracellular growth of BCG in suboptimal cultures of macrophages. T cells expanded with live BCG or lysates of Mycobacterium tuberculosis directly inhibited intracellular BCG. Recent intradermal BCG vaccination significantly enhanced the inhibitory activity of T cells expanded with mycobacterial antigens (P < 0.02), consistent with the induction of memory-immune inhibitory T-cell responses. Selected mycobacterial antigens (Mtb41 > lipoarabinomannan > 38kd > Ag85B > Mtb39) expanded inhibitory T cells, demonstrating the involvement of antigen-specific T cells in intracellular BCG inhibition. We studied the T-cell subsets and molecular mechanisms involved in the memory-immune inhibition of intracellular BCG. Mycobacteria-specific gammadelta T cells were the most potent inhibitors of intracellular BCG growth. Direct contact between T cells and macrophages was necessary for the BCG growth-enhancing and inhibitory activities mediated by control and mycobacteria-specific T cells, respectively. Increases in tumor necrosis factor alpha, interleukin-6, transforming growth factor beta, and vascular endothelial growth factor mRNA expression were associated with the enhancement of intracellular BCG growth. Increases in gamma interferon, FAS, FAS ligand, perforin, granzyme, and granulysin mRNA expression were associated with intracellular BCG inhibition. These culture systems provide in vitro models for studying the opposing T-cell mechanisms involved in mycobacterial survival and protective host immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654790      PMCID: PMC152055          DOI: 10.1128/IAI.71.4.1763-1773.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

Review 1.  [gamma][delta] cells: a right time and a right place for a conserved third way of protection.

Authors:  A C Hayday
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin.

Authors:  S Worku; D F Hoft
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

3.  Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages.

Authors:  J Keane; H G Remold; H Kornfeld
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

4.  Vgamma9/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis.

Authors:  F Dieli; M Troye-Blomberg; J Ivanyi; J J Fournié; M Bonneville; M A Peyrat; G Sireci; A Salerno
Journal:  Eur J Immunol       Date:  2000-05       Impact factor: 5.532

5.  Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination.

Authors:  D F Hoft; C Leonardi; T Milligan; G T Nahass; B Kemp; S Cook; J Tennant; M Carey
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

6.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

7.  Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages.

Authors:  C S Hirsch; J J Ellner; D G Russell; E A Rich
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

8.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

Review 9.  The human T-cell receptor gamma (TRG) genes.

Authors:  M P Lefranc; T H Rabbitts
Journal:  Trends Biochem Sci       Date:  1989-06       Impact factor: 13.807

10.  Fibroblast stimulation in schistosomiasis. I. Stimulation in vitro of fibroblasts by soluble products of egg granulomas.

Authors:  D J Wyler; S M Wahl; A W Cheever; L M Wahl
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

View more
  36 in total

1.  CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses.

Authors:  Steven M Truscott; Getahun Abate; Jeffrey D Price; Claudia Kemper; John P Atkinson; Daniel F Hoft
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection.

Authors:  Wei-Jen Chua; Steven M Truscott; Christopher S Eickhoff; Azra Blazevic; Daniel F Hoft; Ted H Hansen
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

3.  A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.

Authors:  Daniel F Hoft; Azra Blazevic; Getahun Abate; Willem A Hanekom; Gilla Kaplan; Jorge H Soler; Frank Weichold; Larry Geiter; Jerald C Sadoff; Marcus A Horwitz
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

4.  Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity.

Authors:  Charles T Spencer; Getahun Abate; Azra Blazevic; Daniel F Hoft
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

5.  Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.

Authors:  S de Vallière; G Abate; A Blazevic; R M Heuertz; D F Hoft
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route.

Authors:  Ankan Gupta; Nishamol Geetha; Jiju Mani; Pramod Upadhyay; V M Katoch; M Natrajan; U D Gupta; Sangeeta Bhaskar
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

7.  Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.

Authors:  Kousuke Saito; Malika Ait-Goughoulte; Steven M Truscott; Keith Meyer; Azra Blazevic; Getahun Abate; Ratna B Ray; Daniel F Hoft; Ranjit Ray
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

8.  Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells.

Authors:  Ling Shen; Yun Shen; Dan Huang; Liyou Qiu; Prabhat Sehgal; George Z Du; Michael D Miller; Norman L Letvin; Zheng W Chen
Journal:  J Infect Dis       Date:  2004-09-10       Impact factor: 5.226

9.  Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.

Authors:  Jan Andersson; Arina Samarina; Joshua Fink; Sayma Rahman; Susanna Grundström
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

10.  Development of vaccines to control the worldwide tuberculosis pandemic.

Authors:  Daniel F Hoft
Journal:  Mo Med       Date:  2014 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.